Lupin Mira 25 Tablet ER
Marketer
Lupin Ltd
Salt Composition
Mirabegron (25mg)
Overview Lupin Mira 25 Tablet ER
Mira 25 Extended-Release tablets, manufactured by Lupin, alleviate overactive bladder symptoms such as excessive or frequent urination, urgent urination, and urinary incontinence. This medication relaxes the bladder muscles, improving its urine storage capacity. Always adhere to your physician's prescribed dosage and duration. It may be taken with or without food; swallow the tablet whole, avoiding crushing or chewing. Discontinuing treatment prematurely may worsen symptoms, so consult your doctor before stopping. Complete the prescribed course for optimal results. Potential side effects include constipation, headache, hypertension, nasal congestion, urinary tract infection, tachycardia, and arthralgia. Report any persistent or bothersome side effects to your doctor promptly. Before starting treatment, disclose all other medications and pre-existing health conditions, including pregnancy or breastfeeding. Patients with hepatic or renal impairment require close monitoring and regular check-ups as directed by their doctor.
Uses of Lupin Mira 25 Tablet ER
Managing symptoms associated with overactive bladder
Major Benefits of Lupin Mira 25 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Lupin Mira 25 ER tablets. Always swallow the tablet whole; avoid chewing, crushing, or breaking it. This medication can be taken with or without food, but consistency in timing is recommended.
Common Side effects of Lupin Mira 25 Tablet ER:
- Constipation
- Headache
- High blood pressure
- Nasal inflammation
- Urinary tract infection
- Fast heart rate
- Joint pain
How to use Lupin Mira 25 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Lupin Mira 25 Extended-Release tablet whole; avoid crushing, chewing, or breaking it. This medicine can be consumed with or without food, however, consistent timing is recommended.
How Lupin Mira 25 Tablet ER works:
Lupin Mira 25 Extended-Release tablets contain a beta-3 adrenergic agonist. This medication's mechanism involves stimulating bladder receptors, resulting in detrusor muscle relaxation and reduced urinary urgency, frequency, and incontinence.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Lupin Mira 25 Tablet ER with alcohol. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Extended-release Lupin Mira 25 Tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Lupin Mira 25mg tablets may pose a risk to breastfeeding infants. Preliminary studies in humans indicate potential transfer of the medication into breast milk, with possible adverse effects on the child.
DrivingSAFE
Extended-release Lupin Mira 25mg tablets typically do not impair driving ability.
KidneyCAUTION
Extended-release Mira 25 tablets (Lupin) require careful administration in individuals with advanced kidney impairment. Dosage modification for Mira 25 ER tablets may be necessary. Physician consultation is recommended.
LiverCAUTION
Patients with liver impairment should use Mira 25 Extended-Release tablets cautiously, potentially requiring dosage modification. Consult a physician. The medication is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Lupin Mira 25 Tablet ER :
Should you forget a dose of Lupin Mira 25 Extended-Release Tablet, take it immediately. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual medication timetable. Never take a double dose.
Facts to Know About Lupin Mira 25 Tablet ER
| Label | Value |
|---|---|
| Chemical Category | Anilide-based compound |
| Developing Habits | No. |
| Treatment Category | Urological Care |
| Actions | β3-Adrenergic receptor agonist (bladder-selective) |






